Listen to The Lancet Oncology cover art

All Episodes

Listen to The Lancet Oncology — 222 episodes

#
Title
1

In conversation with... Harriet Rumgay

2

In conversation with... Philipp Karschnia

3

In conversation with... Wanda Cui

4

In conversation with... Xuesong Han

5

In conversation with... Ian Tannock

6

In conversation with... M Saiful Huq and Mostafa Aziz Sumon

7

In conversation with... Hisham Mehanna and Sue Yom

8

In conversation with... Mike Sathekge

9

In conversation with... Abdalla Awidi

10

In conversation with... James Nagarajah

11

In conversation with... Ali Landman

12

In conversation with... Kayleigh Bhangdia

13

In conversation with... Dylan Graetz and Erica Kaye

14

In conversation with... Jesse Plascak and Marissa Baker

15

In conversation with... Andre Pfob and Peter Dubsky

16

In conversation with... Gary Rodin

17

In conversation with... Matthias Preusser

18

In conversation with... Andrea Necchi

19

In conversation with... Linda Bi, Ruchit Patel, Chloe Gui, Farshad Nassiri, & Matija Snuderl

20

In conversation with... Jinming Li

21

In conversation with... Caroline Robert

22

In conversation with... Richard Bryant

23

In conversation with... Amar U. Kishan

24

In conversation with... Ariana Znaor on cancer surveillance

25

In conversation with... Yannick Romero

26

In conversation with... Steven Horwitz

27

In conversation with... May Abdel-Wahab and Andrew Scott

28

In conversation with... Zachary Zumsteg

29

In conversation with... Kanwal Raghav

30

In conversation with... Emmy Boerrigter

31

In conversation with... Garth Strohbehn and Katie Lichter

32

In conversation with... James Shultz, Ana Patricia Ortiz, and Leticia Nogueira

33

In conversation with... Bernardo Goulart

34

In conversation with... Maria Kyrgiou

35

In conversation with... Georgios Lyratzopoulos

36

In conversation with... Shankar Siva

37

In conversation with... Neerja Bhatla

38

In conversation with... Chandra Are

39

In conversation with... Ticiana Leal

40

In conversation with... Carlos Fernández de Larrea and Damian Green

41

In conversation with... Madeline Pe

42

In conversation with... Kadia Petricca and Joyce Kambugu

43

In Conversation With... Mark Lythgoe

44

In conversation with... Janet Brown

45

In conversation with... Valerie Speirs

46

In conversation with... Sameer Bakhshi

47

In conversation with... Shankar Siva

48

In conversation with... Mark Lawler and Richard Sullivan

49

In conversation with... Samar Alhomoud

50

In conversation with... Inge Marie Svane

51

In conversation with... Eline Giraud and Elise Smolders

52

In conversation with... Ignace Vergote and Maria Kyrgiou

53

In conversation with... David J Pinato

54

In conversation with... Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr

55

In conversation with... Georgios Lyratzopoulos

56

In conversation with... Lisa Iezzoni and Jordan Marchak

57

In conversation with... Rosie Bradley

58

In conversation with... Yi-Long Wu and Caicun Zhou

59

In conversation with... Rebecca Fitzgerald

60

In conversation with... Elysia Alvarez

61

In conversation with... Aju Mathew

62

In conversation with... David Pinato

63

In conversation with... James Glasbey

64

In conversation with... Manju Sengar and Christopher Booth

65

In conversation with... Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi

66

In conversation with... Rafael Cardoso and Hermann Brenner

67

In conversation with... Takayuki Yoshino

68

In Conversation with… Roberto Orecchia

69

In Conversation with… Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab

70

In Conversation With... Ariana Znaor

71

In Conversation With... Sathira Perera

72

In Conversation With... Geke Hospers

73

The crucial role of oncology nurses in cancer care

74

The effect of climate change on cancer control

75

Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

76

Peptide receptor radionuclide therapy for neuroendocrine tumours

77

Larotrectinib in patients with TRK fusion-positive solid tumours

78

The future of radiotheranostics

79

International standards for the analysis of patient-reported outcomes in cancer trials

80

Presenting symptoms of cancer and stage at diagnosis

81

Global public and philanthropic investment in childhood cancer research

82

Cervical cancer in India

83

Oropharyngeal squamous cell carcinoma

84

Cancer in small island nations

85

Advances in radioimmunotherapy

86

International Neoadjuvant Melanoma Consortium

87

IMWG consensus on imaging in plasma cell disorders

88

Digital oncology

89

Choosing Wisely India

90

Paediatric vertebral radiotherapy

91

Malignant plural mesothelioma

92

CAR T-cell therapy

93

Cervical cancer screening in older women

94

Palliative care in oncology

95

Global review of cancer control

96

Are patient reported outcomes consistent?

97

Changing incidence of adolescent cancer

98

Diffuse intrinsic pontine glioma

99

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer

100

Gender and cancer immunotherapy efficacy

101

PROs in regulatory decision making

102

Vulvar field resection

103

Chromatin organisation and cancer prognosis

104

Trial design for brain metastases: The Lancet Oncology: Jan 2018

105

Lung cancer screening: The Lancet Oncology: November 27, 2017

106

Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017

107

Cancer in Peru: The Lancet Oncology

108

Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017

109

Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

110

Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017

111

EANO and palliative care: The Lancet Oncology: June 2, 2017

112

Head and neck cancer Series: The Lancet Oncology: April 26, 2017

113

<sup>18</sup>F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017

114

Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

115

Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017

116

Cancer survivorship in the USA: The Lancet Oncology: 30 December

117

Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016

118

Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016

119

Renal surveillance: The Lancet Oncology: August 30, 2016

120

Multiple myeloma: The Lancet Oncology: July 26, 2016

121

HPV vaccination in Japan: The Lancet Oncology: June 28, 2016

122

Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016

123

Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016

124

Medulloblastoma: The Lancet Oncology: March 11, 2016

125

NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016

126

Rare cancers: The Lancet Oncology | February 2, 2016

127

Mantle-cell lymphoma: The Lancet Oncology: January 2016

128

Neuro-oncology: The Lancet Oncology, November 2015

129

Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015

130

Breast cancer: The Lancet Oncology: Aug 6, 2015

131

Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015

132

HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015

133

RANO Group: The Lancet Oncology: May 28, 2015

134

HPV and cancer: The Lancet Oncology: April 30, 2015

135

Advances in cancer drug development: The Lancet Oncology: March 18, 2015

136

The Lancet Oncology: March 02, 2015

137

The Lancet Oncology: January 16, 2015

138

The Lancet Oncology: December 16, 2014

139

The Lancet Oncology: November 24, 2014

140

The Lancet Oncology: October 27, 2014

141

The Lancet Oncology: September 17, 2014

142

The Lancet Oncology: August 28, 2014

143

The Lancet Oncology: July 07, 2014

144

The Lancet Oncology: June 30, 2014

145

The Lancet Oncology: May 27, 2014

146

The Lancet Oncology: May 05, 2014

147

The Lancet Oncology: May 02, 2014

148

The Lancet Oncology: March 19, 2014

149

The Lancet Oncology: February 07, 2014

150

The Lancet Oncology: January 14, 2014

151

The Lancet Oncology: December 05, 2013

152

The Lancet Oncology: November 11, 2013

153

The Lancet Oncology: October 14, 2013

154

The Lancet Oncology: September 02, 2013

155

The Lancet Oncology: July 10, 2013

156

The Lancet Oncology: June 07, 2013

157

The Lancet Oncology: May 15, 2013

158

The Lancet Oncology: April 26, 2013

159

The Lancet Oncology: April 16, 2013

160

The Lancet Oncology: April 03, 2013

161

The Lancet Oncology: February 20, 2013

162

The Lancet Oncology: January 25, 2013

163

The Lancet Oncology: December 04, 2012

164

The Lancet Oncology: November 14, 2012

165

The Lancet Oncology: October 30, 2012

166

The Lancet Oncology: August 23, 2012

167

The Lancet Oncology: August 06, 2012

168

The Lancet Oncology: July 13, 2012

169

The Lancet Oncology: June 06, 2012

170

The Lancet Oncology: May 01, 2012

171

The Lancet Oncology: March 23, 2012

172

The Lancet Oncology: February 22, 2012

173

The Lancet Oncology: February 10, 2012

174

The Lancet Oncology: January 30, 2012

175

The Lancet Oncology: November 25, 2011

176

The Lancet Oncology: November 14, 2011

177

The Lancet Oncology: October 28, 2011

178

The Lancet Oncology: September 30, 2011

179

The Lancet Oncology: September 26, 2011

180

The Lancet Oncology: August 26, 2011

181

The Lancet Oncology: July 29, 2011

182

The Lancet Oncology: June 24, 2011

183

The Lancet Oncology: May 27, 2011

184

The Lancet Oncology: April 29, 2011

185

The Lancet Oncology: April 01, 2011

186

The Lancet Oncology: March 01, 2011

187

The Lancet Oncology: January 31, 2011

188

The Lancet Oncology: December 30, 2010

189

The Lancet Oncology: November 29, 2010

190

The Lancet Oncology: November 01, 2010

191

The Lancet Oncology: October 04, 2010

192

The Lancet Oncology: September 01, 2010

193

The Lancet Oncology: August 02, 2010

194

The Lancet Oncology: July 05, 2010

195

The Lancet Oncology: June 01, 2010

196

The Lancet Oncology: April 29, 2010

197

The Lancet Oncology: March 29, 2010

198

The Lancet Oncology: March 01, 2010

199

The Lancet Oncology: February 01, 2010

200

The Lancet Oncology: January 06, 2010

201

The Lancet Oncology: December 01, 2009

202

The Lancet Oncology: October 29, 2009

203

The Lancet Oncology: September 28, 2009

204

The Lancet Oncology: August 27, 2009

205

The Lancet Oncology: July 29, 2009

206

The Lancet Oncology: July 01, 2009

207

The Lancet Oncology: May 28, 2009

208

The Lancet Oncology: April 29, 2009

209

The Lancet Oncology: March 30, 2009

210

The Lancet Oncology: March 05, 2009

211

The Lancet Oncology: January 30, 2009

212

The Lancet Oncology: December 23, 2008

213

The Lancet Oncology: November 26, 2008

214

The Lancet Oncology: October 28, 2008

215

The Lancet Oncology: October 01, 2008

216

The Lancet Oncology: August 26, 2008

217

The Lancet Oncology: August 11, 2008

218

The Lancet Oncology: June 30, 2008

219

The Lancet Oncology: June 09, 2008

220

The Lancet Oncology: April 30, 2008

221

The Lancet Oncology: March 26, 2008

222

The Lancet Oncology: February 25, 2008